{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:07:43Z","timestamp":1782518863590,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Marburg virus (MARV) causes acute hemorrhagic fever that is often lethal, and no licensed vaccines are available for preventing this deadly viral infection. The immune mechanisms for protection against MARV are poorly understood, but previous studies suggest that both antibodies and T cells are required. In our study, we infected BALB\/c mice with plaque-purified, nonlethal MARV and used overlapping peptides to map H2<jats:sup><jats:italic>d<\/jats:italic><\/jats:sup>-restricted CD8+ T-cell epitopes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Splenocytes from mice infected with nonlethal MARV were harvested and stimulated with multiple overlapping 15-mer peptide pools, and reactive CD8+ T cells were evaluated for antigen specificity by measuring upregulation of CD44 and interferon-\u03b3 expression. After confirming positive reactivity to specific 15-mer peptides, we used extrapolated 9-mer epitopes to evaluate the induction of cytotoxic T-cell responses and protection from lethal MARV challenge in BALB\/c mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We discovered a CD8+ T-cell epitope within both the MARV glycoprotein (GP) and nucleoprotein (NP) that triggered cytotoxic T-cell responses. These responses were also protective when epitope-specific splenocytes were transferred into na\u00efve animals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Epitope mapping of MARV GP, NP, and VP40 provides the first evidence that specific MARV-epitope induction of cellular immune responses is sufficient to combat infection. Establishment of CD8+ T-cell epitopes that are reactive to MARV proteins provides an important research tool for dissecting the significance of cellular immune responses in BALB\/c mice infected with MARV.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1743-422x-6-132","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T18:14:45Z","timestamp":1251396885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Discovery of common marburgvirus protective epitopes in a BALB\/c mouse model"],"prefix":"10.1186","volume":"6","author":[{"given":"Warren V","family":"Kalina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L","family":"Warfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene G","family":"Olinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,27]]},"reference":[{"key":"646_CR1","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1371\/journal.pone.0000764","volume":"2","author":"JS Towner","year":"2007","unstructured":"Towner JS, Pourrut X, Albarino CG, Nkogue CN, Bird BH, Grard G, Ksiazek TG, Gonzalez JP, Nichol ST, Leroy EM: Marburg virus infection detected in a common African bat. PLoS ONE 2007, 2: e764. 10.1371\/journal.pone.0000764","journal-title":"PLoS ONE"},{"key":"646_CR2","first-page":"751","volume":"60","author":"VB Andrijich","year":"1981","unstructured":"Andrijich VB: Marburg virus disease. The diagnosis and management of suspected cases. S Afr Med J 1981, 60: 751-753.","journal-title":"S Afr Med J"},{"key":"646_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/bmj.4.5995.489","volume":"4","author":"JS Gear","year":"1975","unstructured":"Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, Meyers AM, Kew MC, Bothwell TH, Sher R, Miller GB, et al.: Outbreake of Marburg virus disease in Johannesburg. Br Med J 1975, 4: 489-493. 10.1136\/bmj.4.5995.489","journal-title":"Br Med J"},{"key":"646_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/viro.1998.9367","volume":"251","author":"M Hevey","year":"1998","unstructured":"Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A: Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 1998, 251: 28-37. 10.1006\/viro.1998.9367","journal-title":"Virology"},{"key":"646_CR5","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","volume":"3","author":"WB Oswald","year":"2007","unstructured":"Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, Jahrling PB, Parren PW, Burton DR: Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys. PLoS Pathog 2007, 3: e9. 10.1371\/journal.ppat.0030009","journal-title":"PLoS Pathog"},{"key":"646_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.vaccine.2006.09.076","volume":"25","author":"A Takada","year":"2007","unstructured":"Takada A, Ebihara H, Jones S, Feldmann H, Kawaoka Y: Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine 2007, 25: 993-999. 10.1016\/j.vaccine.2006.09.076","journal-title":"Vaccine"},{"key":"646_CR7","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.vaccine.2005.11.046","volume":"24","author":"D Wang","year":"2006","unstructured":"Wang D, Schmaljohn AL, Raja NU, Trubey CM, Juompan LY, Luo M, Deitz SB, Yu H, Woraratanadharm J, Holman DH, et al.: De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses. Vaccine 2006, 24: 2975-2986. 10.1016\/j.vaccine.2005.11.046","journal-title":"Vaccine"},{"key":"646_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","volume":"175","author":"KL Warfield","year":"2005","unstructured":"Warfield KL, Olinger G, Deal EM, Swenson DL, Bailey M, Negley DL, Hart MK, Bavari S: Induction of Humoral and CD8+ T Cell Responses Are Required for Protection against Lethal Ebola Virus Infection. J Immunol 2005, 175: 1184-1191.","journal-title":"J Immunol"},{"key":"646_CR9","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","volume":"287","author":"JA Wilson","year":"2000","unstructured":"Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK: Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000, 287: 1664-1666. 10.1126\/science.287.5458.1664","journal-title":"Science"},{"key":"646_CR10","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","volume":"23","author":"DL Swenson","year":"2005","unstructured":"Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S: Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine 2005, 23: 3033-3042. 10.1016\/j.vaccine.2004.11.070","journal-title":"Vaccine"},{"key":"646_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0042-6822(03)00416-1","volume":"314","author":"M Hevey","year":"2003","unstructured":"Hevey M, Negley D, Schmaljohn A: Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes. Virology 2003, 314: 350-357. 10.1016\/S0042-6822(03)00416-1","journal-title":"Virology"},{"key":"646_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrmicro2129","volume":"7","author":"NJ Sullivan","year":"2009","unstructured":"Sullivan NJ, Martin JE, Graham BS, Nabel GJ: Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule. Nat Rev Microbiol 2009, 7: 393-400. 10.1038\/nrmicro2129","journal-title":"Nat Rev Microbiol"},{"key":"646_CR13","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/eji.200737196","volume":"37","author":"JD Brien","year":"2007","unstructured":"Brien JD, Uhrlaub JL, Nikolich-Zugich J: Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur J Immunol 2007, 37: 1855-1863. 10.1002\/eji.200737196","journal-title":"Eur J Immunol"},{"key":"646_CR14","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","volume":"75","author":"JA Wilson","year":"2001","unstructured":"Wilson JA, Hart MK: Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. J Virol 2001, 75: 2660-2664. 10.1128\/JVI.75.6.2660-2664.2001","journal-title":"J Virol"},{"key":"646_CR15","doi-asserted-by":"publisher","first-page":"14189","DOI":"10.1128\/JVI.79.22.14189-14196.2005","volume":"79","author":"GG Olinger","year":"2005","unstructured":"Olinger GG, Bailey MA, Dye JM, Bakken R, Kuehne A, Kondig J, Wilson J, Hogan RJ, Hart MK: Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. J Virol 2005, 79: 14189-14196. 10.1128\/JVI.79.22.14189-14196.2005","journal-title":"J Virol"},{"key":"646_CR16","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1128\/JVI.75.23.11457-11463.2001","volume":"75","author":"CH Pan","year":"2001","unstructured":"Pan CH, Chen HW, Huang HW, Tao MH: Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses. J Virol 2001, 75: 11457-11463. 10.1128\/JVI.75.23.11457-11463.2001","journal-title":"J Virol"},{"key":"646_CR17","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1128\/JVI.00126-09","volume":"83","author":"KL Warfield","year":"2009","unstructured":"Warfield KL, Bradfute SB, Wells J, Lofts L, Cooper MT, Alves DA, Reed DK, VanTongeren SA, Mech CA, Bavari S: Development and characterization of a mouse model for Marburg hemorrhagic fever. J Virol 2009, 83: 6404-6415. 10.1128\/JVI.00126-09","journal-title":"J Virol"},{"key":"646_CR18","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.4049\/jimmunol.174.7.4198","volume":"174","author":"M Gupta","year":"2005","unstructured":"Gupta M, Greer P, Mahanty S, Shieh WJ, Zaki SR, Ahmed R, Rollin PE: CD8-Mediated Protection against Ebola Virus Infection Is Perforin Dependent. J Immunol 2005, 174: 4198-4202.","journal-title":"J Immunol"},{"key":"646_CR19","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1097\/01.TP.0000058745.02123.6F","volume":"75","author":"MA Sherritt","year":"2003","unstructured":"Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE, Kear LM, Slaughter RE, Bell SC, Galbraith AJ, et al.: Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation 2003, 75: 1556-1560. 10.1097\/01.TP.0000058745.02123.6F","journal-title":"Transplantation"},{"key":"646_CR20","doi-asserted-by":"publisher","first-page":"8264","DOI":"10.4049\/jimmunol.179.12.8264","volume":"179","author":"S Vallbracht","year":"2007","unstructured":"Vallbracht S, Jessen B, Mrusek S, Enders A, Collins PL, Ehl S, Krempl CD: Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus. J Immunol 2007, 179: 8264-8273.","journal-title":"J Immunol"},{"key":"646_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/vim.2004.17.390","volume":"17","author":"DS Reed","year":"2004","unstructured":"Reed DS, Hensley LE, Geisbert JB, Jahrling PB, Geisbert TW: Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol 2004, 17: 390-400. 10.1089\/vim.2004.17.390","journal-title":"Viral Immunol"},{"key":"646_CR22","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/JVI.73.4.3491-3496.1999","volume":"73","author":"BH Harcourt","year":"1999","unstructured":"Harcourt BH, Sanchez A, Offermann MK: Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. J Virol 1999, 73: 3491-3496.","journal-title":"J Virol"},{"key":"646_CR23","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1086\/379199","volume":"188","author":"CM Bosio","year":"2003","unstructured":"Bosio CM, Aman MJ, Grogan C, Hogan R, Ruthel G, Negley D, Mohamadzadeh M, Bavari S, Schmaljohn A: Ebola and Marburg Viruses Replicate in Monocyte-Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation. J Infect Dis 2003, 188: 1630-1638. 10.1086\/379199","journal-title":"J Infect Dis"},{"key":"646_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.virol.2004.05.025","volume":"326","author":"CM Bosio","year":"2004","unstructured":"Bosio CM, Moore BD, Warfield KL, Ruthel G, Mohamadzadeh M, Aman MJ, Bavari S: Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology 2004, 326: 280-287. 10.1016\/j.virol.2004.05.025","journal-title":"Virology"},{"key":"646_CR25","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/jvi.76.5.2518-2528.2002","volume":"76","author":"G Simmons","year":"2002","unstructured":"Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P: Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 2002, 76: 2518-2528. 10.1128\/jvi.76.5.2518-2528.2002","journal-title":"J Virol"},{"key":"646_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/intimm\/10.5.619","volume":"10","author":"N Pardigon","year":"1998","unstructured":"Pardigon N, Bercovici N, Calbo S, Santos-Lima EC, Liblau R, Kourilsky P, Abastado JP: Role of co-stimulation in CD8+ T cell activation. Int Immunol 1998, 10: 619-630. 10.1093\/intimm\/10.5.619","journal-title":"Int Immunol"},{"key":"646_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/78645","volume":"6","author":"ZY Yang","year":"2000","unstructured":"Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ: Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000, 6: 886-889. 10.1038\/78645","journal-title":"Nat Med"},{"key":"646_CR28","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1128\/JVI.01586-06","volume":"81","author":"CA Zampieri","year":"2007","unstructured":"Zampieri CA, Fortin JF, Nolan GP, Nabel GJ: The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J Virol 2007, 81: 1230-1240. 10.1128\/JVI.01586-06","journal-title":"J Virol"},{"key":"646_CR29","doi-asserted-by":"publisher","first-page":"15951","DOI":"10.1074\/jbc.M601796200","volume":"281","author":"JH Kuhn","year":"2006","unstructured":"Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, Vincent MJ, Towner JS, Nichol ST, Bavari S, Choe H, et al.: Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a shared receptor. J Biol Chem 2006, 281: 15951-15958. 10.1074\/jbc.M601796200","journal-title":"J Biol Chem"},{"key":"646_CR30","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.1128\/JVI.00959-06","volume":"80","author":"KM Daddario-DiCaprio","year":"2006","unstructured":"Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, Stroher U, Hensley LE, Grolla A, Fritz EA, Feldmann F, Feldmann H, Jones SM: Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol 2006, 80: 9659-9666. 10.1128\/JVI.00959-06","journal-title":"J Virol"},{"key":"646_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0928-8244(03)00273-6","volume":"40","author":"DL Swenson","year":"2004","unstructured":"Swenson DL, Warfield KL, Kuehl K, Larsen T, Hevey MC, Schmaljohn A, Bavari S, Aman MJ: Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunol Med Microbiol 2004, 40: 27-31. 10.1016\/S0928-8244(03)00273-6","journal-title":"FEMS Immunol Med Microbiol"},{"key":"646_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1586\/14760584.7.4.417","volume":"7","author":"DL Swenson","year":"2008","unstructured":"Swenson DL, Warfield KL, Larsen T, Alves DA, Coberley SS, Bavari S: Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines 2008, 7: 417-429. 10.1586\/14760584.7.4.417","journal-title":"Expert Rev Vaccines"},{"key":"646_CR33","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1016\/j.vaccine.2004.01.063","volume":"22","author":"KL Warfield","year":"2004","unstructured":"Warfield KL, Swenson DL, Negley DL, Schmaljohn AL, Aman MJ, Bavari S: Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection. Vaccine 2004, 22: 3495-3502. 10.1016\/j.vaccine.2004.01.063","journal-title":"Vaccine"},{"key":"646_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1743-422X-4-108","volume":"4","author":"KL Warfield","year":"2007","unstructured":"Warfield KL, Alves DA, Bradfute SB, Reed DK, Vantongeren S, Kalina WV, Olinger GG, Bavari S: Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol J 2007, 4: 108. 10.1186\/1743-422X-4-108","journal-title":"Virol J"},{"key":"646_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","volume":"152","author":"KC Parker","year":"1994","unstructured":"Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994, 152: 163-175.","journal-title":"J Immunol"},{"key":"646_CR36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1086\/515386","volume":"178","author":"M Bray","year":"1998","unstructured":"Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J: A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998, 178: 651-661. 10.1086\/515386","journal-title":"J Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-6-132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T14:05:57Z","timestamp":1685109957000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-6-132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,27]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["646"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-6-132","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,27]]},"assertion":[{"value":"27 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"132"}}